P0DMV8 (HS71A_HUMAN) Homo sapiens (Human)
Heat shock 70 kDa protein 1A UniProtKBInterProInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
77 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Atomic cryoEM structure of Hsp90-Hsp70-Hop-GR |
Heteromer P04150; P07900; P31948; | 100.0 | 2×ADP; 2×MG; 2×K; | |||
| Crystal structure of the complex between the BAG5 BD5 and Hsp70 NBD |
Heteromer Q9UL15; | 100 | 1×TRS; | |||
| The complex crystals structure of the FAF1 UBL1_L-Hsp70 NBD with ADP and phosphate |
Heteromer Q9UNN5; | 100.0 | 1×ADP; 1×MG; 1×PO4; | |||
| Crystal structure of a complex of Sse1p and Hsp70 |
Heteromer P32589; | 100 | 3×MG; 1×K; 1×ATP; 1×GOL; | |||
| Crystal structure of a complex of Sse1p and Hsp70, Selenomethionine-labeled crystals |
Heteromer P32589; | 100 | 1×MG; 1×ATP; 1×GOL; | |||
| Crystal structure of the HspBP1 core domain complexed with the fragment of Hsp70 ATPase domain |
Heteromer Q9NZL4; | 100 | 1×AMP; | |||
| NMR structure of the second TPR domain of the human RPAP3 protein in complex with HSP70 peptide SGP… |
Heteromer P0DMV9; Q9H6T3; | 100 | ||||
| Crystal structure of the TPR domain of CHIP complexed with Hsp70-C peptide |
Heteromer Q9WUD1; | 100 | ||||
| Crystal structure of a fusion protein containing the NBD of Hsp70 and the middle domain of Hip | homo-2-mer | 100 | 2×ADP; 2×MG; 2×PO4; 34×IOD; | |||
| Structural analysis of AIMP2-DX2 and HSP70 interaction | homo-2-mer | 100 | ||||
| Structural analysis of AIMP2-DX2 and HSP70 interaction | homo-2-mer | 100 | ||||
| C-terminal domain of human heat shock 70kDa protein 1B. | homo-2-mer | 100 | ||||
| Crystal structure of the human Hsp70 ATPase domain in the apo form | monomer | 100 | 1×ZN; | |||
| Structure of tellurium-centred Anderson-Evans polyoxotungstate (TEW) bound to the nucleotide bindin… | monomer | 100 | 1×ADP; 1×TEW; 1×MG; 1×PO4; 2×NA; | |||
| Crystal structure of human Hsp70 NBD in the ADP-bound and Mg ion-free state | monomer | 100 | 1×ADP; 1×K; 1×CL; | |||
| HSP72 with adenosine-derived inhibitor | monomer | 100 | 1×SGV; 4×EDO; | |||
| Crystal structure of the human Hsp70 ATPase domain in complex with AMP-PNP | monomer | 100 | 1×MG; 1×ANP; | |||
| The crystal structure of the human Hsp70 ATPase domain | monomer | 99.74 | 1×PO4; 2×CA; 2×NA; 1×ADP; | |||
| HSP72-NBD bound to compound TCI 8 - Tyr15 in up-conformation | monomer | 100.0 | 1×TI8; 1×FLC; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 5.70 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 1.14 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 11.40 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 2.28 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 7.98 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 6.84 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 12.54 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 13.68 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 14.82 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 17.10 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 3.42 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 9.12 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 4.56 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 15.96 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal Structure of HSP72 in complex with ligand 10 at 10.26 MGy X-ray dose. | monomer | 100 | 2×PO4; 1×EDO; 1×GBA; 1×MG; | |||
| Crystal structure of ADP and Pi bound human Hsp70 NBD mutant R272K. | monomer | 99.74 | 1×ADP; 3×PO4; 1×MG; 2×NA; 1×EPE; 1×CL; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 14.30 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 17.16 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 7.15 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 10.01 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 12.87 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 15.73 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 8.58 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 18.59 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 21.45 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 20.02 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 4.29 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 2.86 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 5.72 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 1.43 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| Crystal Structure of HSP72 in complex with ligand 11 at 11.44 MGy X-ray dose | monomer | 100 | 4×PO4; 3×DMS; 5×EDO; 1×PEG; 1×1PS; 1×A1ACZ; | |||
| ATPase domain of human heat shock 70kDa protein 1 | monomer | 100 | 1×CA; 1×CL; 1×ADP; | |||
| Crystal structure of nucleotide-free human Hsp70 NBD. | monomer | 100 | 1×EPE; 2×MG; 4×PO4; 1×CL; 1×NA; | |||
| Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues | monomer | 100 | 1×ADN; 21×EDO; 1×DMS; 1×MG; | |||
| Crystal structure of human Hsp70 NBD in the ADP- and Mg ion-bound state | monomer | 100 | 1×ADP; 1×PO4; 1×MG; 1×NA; 1×PG0; | |||
| Crystal structure of ADP bound human Hsp70 NBD mutant R272K. | monomer | 99.74 | 1×ADP; 1×EPE; 1×CL; 1×PO4; 1×NA; | |||
| Crystal structure of human Hsp70 NBD in the ADP-, Mg ion-, and K ion-bound state | monomer | 100 | 1×ADP; 1×PO4; 1×MG; 1×K; 1×CL; 1×CA; | |||
| Crystal structure of human HSP72-NBD in complex with fragment 1 | monomer | 100 | 1×MG; 1×8X6; 1×PO4; | |||
| Structure of tellurium-centred Anderson-Evans polyoxotungstate (TEW) bound to the nucleotide bindin… | monomer | 100 | 1×ADP; 1×MG; 1×PO4; 3×NA; 2×TEW; | |||
| Crystal structure of HSP70 ATPase domain in complex with ADP and calcium | monomer | 99.73 | 1×ADP; 2×CA; | |||
| Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues | monomer | 100.0 | 1×5P7; 1×PO4; 1×DTV; 12×EDO; 1×MG; | |||
| Structure of a modified protein containing a genetically encoded phosphoserine | monomer | 99.73 | 1×ADP; 1×PO4; 1×MG; 1×K; | |||
| Crystal structure of unhydrolyzed ATP bound human Hsp70 NBD double mutant E268Q+R272K. | monomer | 99.47 | 1×ATP; 2×CL; 1×MG; 1×NA; | |||
| HSP72 with adenosine-derived inhibitor | monomer | 100.0 | 1×GB8; 3×GOL; 2×DMS; 1×CL; | |||
| HSP72-NBD bound to compound TCI 8 - Tyr15 in down-conformation | monomer | 100 | 1×TI8; | |||
| Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues | monomer | 100 | 1×KC7; 2×DMS; 1×CL; | |||
| Crystal structure of the human 70kDa heat shock protein 1A (Hsp70-1) ATPase domain in complex with … | monomer | 100 | 1×ADP; 1×MG; 1×PO4; | |||
| X-ray crystal structure of Y149A mutated Hsp72-NBD in complex with AMPPnP | monomer | 99.73 | 2×MG; 1×CL; 1×ANP; | |||
| X-ray crystal structure of Y149A mutated Hsp72-NBD in complex with ADP | monomer | 99.73 | 1×ADP; 1×MG; 1×CL; 1×K; 1×PO4; | |||
| Crystal structure of human HSP70 complexed with 4-{(2R,3S,4R)-5-[(R)-6-Amino-8-(3,4-dichloro-benzyl… | monomer | 99.73 | 1×3FD; | |||
| Joint neutron and X-ray crystal structure of the nucleotide-binding domain of Hsp72 in complex with… | monomer | 100 | 1×ADP; 1×MG; 1×NA; | |||
| Crystal structure of nucleotide-free human Hsp70 NBD double mutant E268Q+R272K. | monomer | 99.46 | 1×CL; 2×PO4; 1×TRS; | |||
| Glutathionylated hHsp70 SBD | monomer | 100 | ||||
| Solution structure for human HSP70 substrate binding domain | monomer | 100 | ||||
| Solution structure for human HSP70 substrate binding domain L542Y mutant | monomer | 99.46 | ||||
| HEAT SHOCK PROTEIN 70 SUBSTRATE BINDING DOMAIN | monomer | 100.0 | 1×GOL; | |||
| HEAT SHOCK PROTEIN 70 SUBSTRATE BINDING DOMAIN WITH COVALENTLY LINKED NOVOLACTONE | monomer | 100.0 | 1×3UM; | |||
| Solution Structure of The C-terminal Domain (537-610) of Human Heat Shock Protein 70 | monomer | 100 | ||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7o6r.1.A | monomer | 0.85 | 1×LZ1; 2×K; 1×TMO; | 88.63 | ||
| 3c7n.1.B | monomer | 0.79 | 1×MG; | 88.81 | ||
| 7sqc.391.A | monomer | 0.79 | 74.38 | |||
| 7kzi.1.A | monomer | 0.73 | 49.67 | |||
| 7kw7.1.C | monomer | 0.69 | 1×ADP; 1×K; | 100.00 | ||
6 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 7o6r.1.A | monomer | 0.82 | 1×LZ1; 1×K; 1×TMO; | 88.98 | ||
| Isoform 2 | 3c7n.1.B | monomer | 0.77 | 1×MG; | 88.98 | ||
| Isoform 2 | 7sqc.391.A | monomer | 0.74 | 75.21 | |||
| Isoform 2 | 2kho.1.A | monomer | 0.72 | 50.00 | |||
| Isoform 2 | 7kzi.1.A | monomer | 0.71 | 49.45 | |||
| Isoform 2 | 7kw7.1.C | monomer | 0.66 | 1×ADP; 1×K; | 99.49 | ||